Kiromic BioPharma Inc

NASDAQ:KRBP   12:04:55 PM EDT
10.50
+0.29 (+2.84%)
Products

Kiromic Announces FDA Ind Submission First-In-Human, Ai Derived Off-The-Shelf Isomesothelin Gamma Delta Car T-Cell Therapy

Published: 05/24/2021 12:30 GMT
Kiromic BioPharma Inc (KRBP) - Kiromic Announces FDA Ind Submission First-in-human, Ai Derived Off-the-shelf Isomesothelin Gamma Delta Car T-cell Therapy, 30 Days Before the End of the Second Quarter.